Ad
related to: strep b prevention
Search results
Results From The WOW.Com Content Network
Invasive GBS infections in non-pregnant adults convey a rising hardship in most developed countries. Vaccination to prevent GBS infection could be a crucial approach to prevent GBS disease in adults. [130] [131] Toxic shock syndrome (TSS) is an acute multisystem life-threatening disease resulting in multiple organ failure. The severity of this ...
GBS urinary tract infections (UTI) may also induce labor and cause premature delivery. [3] In the western world, GBS (in the absence of effective prevention measures) is the major cause of several bacterial infections of the newborn neonatal infection sepsis, pneumonia, and meningitis, which can lead to death or long-term sequelae. [3]
Played a part in causing the 2003 RCOG risk-based guidelines on the prevention of early-onset group B Strep infection, and continues to campaign for improved guidelines and awareness in medical professionals. [11] Raised significant public awareness of group B Strep and the impact a group B Strep infection can have on newborn babies if not ...
Nov. 5—Strep throat cases among children are surging across the U.S., and a shortage of antibiotics to treat them could pose risks. Along with the typical cold and flu season, people should be ...
S. agalactiae, or group B streptococcus, GBS, causes pneumonia and meningitis in newborns and the elderly, with occasional systemic bacteremia. Importantly, Streptococcus agalactiae is the most common cause of meningitis in infants from one month to three months old.
Most experts estimate that about one in 100 campylobacter strains carry the GBS risk, and one in 100 people infected with such a strain develop GBS, making the overall risk roughly one in 10,000.
A GBS vaccine is currently being tested but not currently available. Vaccination is estimated to being able to prevent 4% of GBS infections for preterm births and 60–70% for neonatal GBS infections in the US. The projected benefits of maternal vaccination is the prevention of 899 cases of GBS disease and 35 deaths among infants.
Guillain–Barré syndrome (also called "GBS") is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system. [3] Typically, both sides of the body are involved, and the initial symptoms are changes in sensation or pain often in the back along with muscle weakness, beginning in the feet and hands, often spreading to the arms and upper body. [3]